Improved Anticancer Effect of Magnetite Nanocomposite Formulation of GALLIC Acid (Fe₃O₄-PEG-GA) Against Lung, Breast and Colon Cancer Cells

Overview

Journal Nanomaterials (Basel)

Date 2018 Feb 3

PMID 29393902

Citations 19

Authors

Raihana Rosman

Bullo Saifullah

Sandra Maniam

Dena Dorniani

Mohd Zobir Hussein

Sharida Fakurazi

Affiliations

Soon will be listed here.

Abstract

Lung cancer, breast cancer and colorectal cancer are the most prevalent fatal types of cancers globally. Gallic acid (3,4,5-trihydroxybenzoic acid) is a bioactive compound found in plants and foods, such as white tea, witch hazel and it has been reported to possess anticancer, antioxidant and anti-inflammatory properties. In this study we have redesigned our previously reported anticancer nanocomposite formulation with improved drug loading based on iron oxide magnetite nanoparticles coated with polyethylene glycol and loaded with anticancer drug gallic acid (Fe₃O₄-PEG-GA). The in vitro release profile and percentage drug loading were found to be better than our previously reported formulation. The anticancer activity of pure gallic acid (GA), empty carrier (Fe₃O₄-PEG) nanocarrier and of anticancer nanocomposite (Fe₃O₄-PEG-GA) were screened against human lung cancer cells (A549), human breast cancer cells (MCF-7), human colon cancer cells (HT-29) and normal fibroblast cells (3T3) after incubation of 24, 48 and 72 h using (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) MTT assay. The designed formulation (Fe₃O₄-PEG-GA) showed better anticancer activity than free gallic acid (GA). The results of the in vitro studies are highly encouraging to conduct the in vivo studies.

Citing Articles

Antioxidant, Antitumoral, Antimicrobial, and Prebiotic Activity of Magnetite Nanoparticles Loaded with Bee Pollen/Bee Bread Extracts and 5-Fluorouracil.

Ilie C, Spoiala A, Chircov C, Dolete G, Oprea O, Vasile B Antioxidants (Basel). 2024; 13(8).

PMID: 39199141 PMC: 11351729. DOI: 10.3390/antiox13080895.

Gallic acid suppresses the progression of clear cell renal cell carcinoma through inducing autophagy via the PI3K/Akt/Atg16L1 signaling pathway.

Zhang T, Zhang X, Fei Y, Lu J, Zhou D, Zhang L Int J Oncol. 2024; 65(1).

PMID: 38818827 PMC: 11173374. DOI: 10.3892/ijo.2024.5658.

Tumor acidification and GSH depletion by bimetallic composite nanoparticles for enhanced chemodynamic therapy of TNBC.

Chen W, Hu F, Gao Q, Zheng C, Bai Q, Liu J J Nanobiotechnology. 2024; 22(1):98.

PMID: 38461231 PMC: 10924346. DOI: 10.1186/s12951-024-02308-8.

Current Advances in Nanotechnology-Mediated Delivery of Herbal and Plant-Derived Medicines.

Jalili A, Bagherifar R, Nokhodchi A, Conway B, Javadzadeh Y Adv Pharm Bull. 2023; 13(4):712-722.

PMID: 38022806 PMC: 10676547. DOI: 10.34172/apb.2023.087.

An update on the potential mechanism of gallic acid as an antibacterial and anticancer agent.

Keyvani-Ghamsari S, Rahimi M, Khorsandi K Food Sci Nutr. 2023; 11(10):5856-5872.

PMID: 37823155 PMC: 10563697. DOI: 10.1002/fsn3.3615.

References

Barahuie F, Dorniani D, Saifullah B, Gothai S, Hussein M, Pandurangan A . Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system. Int J Nanomedicine. 2017; 12:2361-2372. PMC: 5376211. DOI: 10.2147/IJN.S126245. View

Saini V, Sewal R, Ahmad Y, Medhi B . Prospective Observational Study of Adverse Drug Reactions of Anticancer Drugs Used in Cancer Treatment in a Tertiary Care Hospital. Indian J Pharm Sci. 2016; 77(6):687-93. PMC: 4778228. DOI: 10.4103/0250-474x.174990. View

Yang H, Hua M, Liu H, Huang C, Wei K . Potential of magnetic nanoparticles for targeted drug delivery. Nanotechnol Sci Appl. 2013; 5:73-86. PMC: 3781723. DOI: 10.2147/NSA.S35506. View

Li Y, Wang Y, Tu L, Chen D, Luo Z, Liu D . Sub-Acute Toxicity Study of Graphene Oxide in the Sprague-Dawley Rat. Int J Environ Res Public Health. 2016; 13(11). PMC: 5129359. DOI: 10.3390/ijerph13111149. View

Zhou Y, Jing X, Chen Y . Material chemistry of graphene oxide-based nanocomposites for theranostic nanomedicine. J Mater Chem B. 2020; 5(32):6451-6470. DOI: 10.1039/c7tb00680b. View

Saifullah B, Maitra A, Chrzastek A, Naeemullah B, Fakurazi S, Bhakta S . Nano-Formulation of Ethambutol with Multifunctional Graphene Oxide and Magnetic Nanoparticles Retains Its Anti-Tubercular Activity with Prospects of Improving Chemotherapeutic Efficacy. Molecules. 2017; 22(10). PMC: 6151652. DOI: 10.3390/molecules22101697. View

Hsieh Y, Liao C, Chen W, Pai J, Weng M . Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition. J Cell Biochem. 2017; 118(12):4639-4651. DOI: 10.1002/jcb.26128. View

Vishnubhakthula S, Elupula R, Duran-Lara E . Recent Advances in Hydrogel-Based Drug Delivery for Melanoma Cancer Therapy: A Mini Review. J Drug Deliv. 2017; 2017:7275985. PMC: 5567449. DOI: 10.1155/2017/7275985. View

Maurya D, Nandakumar N, Devasagayam T . Anticancer property of gallic acid in A549, a human lung adenocarcinoma cell line, and possible mechanisms. J Clin Biochem Nutr. 2011; 48(1):85-90. PMC: 3022071. DOI: 10.3164/jcbn.11-004FR. View

10.

Saifullah B, Chrzastek A, Maitra A, Naeemullah B, Fakurazi S, Bhakta S . Novel Anti-Tuberculosis Nanodelivery Formulation of Ethambutol with Graphene Oxide. Molecules. 2017; 22(10). PMC: 6151756. DOI: 10.3390/molecules22101560. View

11.

Liu Z, Liu J, Wang T, Li Q, Francis P, Barrow C . Switching off the interactions between graphene oxide and doxorubicin using vitamin C: combining simplicity and efficiency in drug delivery. J Mater Chem B. 2020; 6(8):1251-1259. DOI: 10.1039/c7tb03063k. View

12.

Agustoni F, Platania M, Vitali M, Zilembo N, Haspinger E, Sinno V . Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders. Cancer Treat Rev. 2013; 40(1):197-203. DOI: 10.1016/j.ctrv.2013.05.005. View

13.

Roe O . The High Cost of New Cancer Therapies-A Challenge of Inequality for All Countries. JAMA Oncol. 2016; 3(9):1169-1170. DOI: 10.1001/jamaoncol.2016.6335. View

14.

Xu L, Wan C, Du J, Li H, Liu X, Yang H . Synthesis, characterization, and in vitro evaluation of targeted gold nanoshelled poly(d,l-lactide-co-glycolide) nanoparticles carrying anti p53 antibody as a theranostic agent for ultrasound contrast imaging and photothermal therapy. J Biomater Sci Polym Ed. 2017; 28(4):415-430. DOI: 10.1080/09205063.2016.1277828. View

15.

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

16.

Revia R, Zhang M . Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances. Mater Today (Kidlington). 2016; 19(3):157-168. PMC: 4981486. DOI: 10.1016/j.mattod.2015.08.022. View

17.

Chung C, Kim Y, Shin D, Ryoo S, Hong B, Min D . Biomedical applications of graphene and graphene oxide. Acc Chem Res. 2013; 46(10):2211-24. DOI: 10.1021/ar300159f. View

18.

Dorniani D, Hussein M, Kura A, Fakurazi S, Shaari A, Ahmad Z . Sustained release of prindopril erbumine from its chitosan-coated magnetic nanoparticles for biomedical applications. Int J Mol Sci. 2013; 14(12):23639-53. PMC: 3876068. DOI: 10.3390/ijms141223639. View

19.

Ohno Y, Fukuda K, Takemura G, Toyota M, Watanabe M, Yasuda N . Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs. 1999; 10(9):845-51. DOI: 10.1097/00001813-199910000-00008. View

20.

Dorniani D, Hussein M, Kura A, Fakurazi S, Shaari A, Ahmad Z . Preparation of Fe₃O₄ magnetic nanoparticles coated with gallic acid for drug delivery. Int J Nanomedicine. 2012; 7:5745-56. PMC: 3500033. DOI: 10.2147/IJN.S35746. View